Thrombus clinical trials

Explore recruiting thrombus clinical trials.

Recruiting thrombus studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thrombus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device-related intra-cardiac thrombus: a randomized Assessment Under direct oral anticoagulant and vitamin K antagonist Therapy – the ARGONAUT trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An investigator-initiated, multicenter, open-label, parallel arm, active comparator, randomized study to compare the efficacy of apixaban versus warfarin with respect to thrombus resolution in patients with left ventricular thrombus after acute myocardial infarction.

Sweden, Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Impact of Oral Semaglutide on Platelet Reactivity in Patients with Diabetes Mellitus or Overweight with High Risk or established Cardiovascular Disease: the SEMA-PLAT Study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE

France

Therapeutic use (Phase IV) EU CTIS Study details

Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI: an open label randomized controlled multicenter Phase-II study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

PERCUTANEOUS EMBOLECTOMY, LOW DOSE THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Thrombus trials by city

Thrombus in Toronto Thrombus in Vancouver Thrombus in Montreal Thrombus in Calgary Thrombus in Edmonton Thrombus in Ottawa Thrombus in Winnipeg Thrombus in Quebec City Thrombus in Hamilton Thrombus in Kitchener Thrombus in London Thrombus in Halifax Thrombus in New York Thrombus in Los Angeles Thrombus in Chicago Thrombus in Houston

Thrombus clinical trials

Recruiting thrombus studies right now

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

DOAC - Dosing Options in AntiCoagulation Prophylaxis

TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study

Is Clonal Hematopoiesis of Indeterminate Potential Associated With Unprovoked Pulmonary Embolism?

Supplemental Oxygen in Pulmonary Embolism (SO-PE)

Pharmaco Mechanical Thrombolysis Associated With Anticoagulation Compared With Anticoagulation in the Acute Phase of Very Symptomatic Proximal Venous Thrombosis of the Lower Limbs.

Low INR to Minimize Bleeding With Mechanical Valves Trial

Intracardiac Echocardiography Guided Watchman Device Implant

Coagulation in Cirrhosis

Also recruiting in Europe

Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device-related intra-cardiac thrombus: a randomized Assessment Under direct oral anticoagulant and vitamin K antagonist Therapy – the ARGONAUT trial

An investigator-initiated, multicenter, open-label, parallel arm, active comparator, randomized study to compare the efficacy of apixaban versus warfarin with respect to thrombus resolution in patients with left ventricular thrombus after acute myocardial infarction.

Impact of Oral Semaglutide on Platelet Reactivity in Patients with Diabetes Mellitus or Overweight with High Risk or established Cardiovascular Disease: the SEMA-PLAT Study

AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE

Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI: an open label randomized controlled multicenter Phase-II study

PERCUTANEOUS EMBOLECTOMY, LOW DOSE THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM

Thrombus trials by city

Other conditions